We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
-6.83%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$116M
AUM Growth
-$26.7M
(-19%)
Cap. Flow
-$11M
Cap. Flow
% of AUM
-9.44%
Top 10 Holdings %
Top 10 Hldgs %
31.93%
Holding
117
New
6
Increased
16
Reduced
64
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HTGM
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
|
+$1.97M |
| 2 |
Exagen
XGN
|
+$1.41M |
| 3 |
BioLife Solutions
BLFS
|
+$1.1M |
| 4 |
AVGR
Avinger, Inc. Common Stock
AVGR
|
+$1.08M |
| 5 |
Castle Biosciences
CSTL
|
+$619K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Magnite
MGNI
|
+$2.1M |
| 2 |
Digital Turbine
APPS
|
+$1.92M |
| 3 |
CryoPort
CYRX
|
+$1.22M |
| 4 |
Expeditors International
EXPD
|
+$797K |
| 5 |
Veracyte
VCYT
|
+$565K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 62.15% |
| 2 | Technology | 13.69% |
| 3 | Communication Services | 6.62% |
| 4 | Industrials | 5.98% |
| 5 | Consumer Staples | 2.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Champions Oncology
CSBR
$74.5M
| $370K | 0.32% |
65,500
-77,050
| -54% | -$500K |
|
77
Sportsman's Warehouse
SPWH
$44.5M
| $368K | 0.32% |
71,000
-48,500
| -41% | -$209K |
|
78
Fastenal
FAST
$54.7B
| $356K | 0.31% |
21,800
| – | – |
|
79
Best Buy
BBY
$18.2B
| $338K | 0.29% |
4,900
-100
| -2% | -$6.97K |
|
80
DarioHealth
DRIO
$70.9M
| $327K | 0.28% |
2,687
| – | – |
|
|
AMRN
81
Amarin Corp
AMRN
$299M
| $326K | 0.28% |
1,075
-45
| -4% | -$15.7K |
|
82
Radiant Logistics
RLGT
$386M
| $302K | 0.26% |
58,500
-38,500
| -40% | -$200K |
|
83
Asure Software
ASUR
$232M
| $285K | 0.25% |
42,500
-22,500
| -35% | -$171K |
|
84
NXP Semiconductors
NXPI
$57.8B
| $278K | 0.24% |
+2,550
| New | +$260K |
|
85
Apple
AAPL
$4.54T
| $269K | 0.23% |
4,800
| – | – |
|
86
Dyadic International
DYAI
$38.3M
| $261K | 0.22% |
42,500
| – | – |
|
87
Option Care Health
OPCH
$3.45B
| $259K | 0.22% |
20,250
-31,250
| -61% | -$385K |
|
88
IZEA Worldwide
IZEA
$60.6M
| $256K | 0.22% |
248,075
-17,750
| -7% | -$28.5K |
|
|
VERO
89
DELISTED
Venus Concept
VERO
| $244K | 0.21% |
152
| – | – |
|
|
TONX
90
TON Strategy Co
TONX
$168M
| $226K | 0.19% |
26
-3
| -10% | -$37.7K |
|
91
GE Aerospace
GE
$374B
| $221K | 0.19% |
4,968
+1,505
| +43% | +$70.7K |
|
|
BREW
92
DELISTED
Craft Brew Alliance, Inc.
BREW
| $188K | 0.16% |
22,950
-12,500
| -35% | -$156K |
|
|
SOLO
93
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
| $184K | 0.16% |
90,520
| – | – |
|
|
ZIXI
94
DELISTED
Zix Corporation
ZIXI
| $181K | 0.16% |
25,000
-3,000
| -11% | -$25K |
|
|
VRML
95
DELISTED
Vermillion, Inc.
VRML
| $176K | 0.15% |
+336,000
| New | +$222K |
|
|
VRAY
96
DELISTED
ViewRay, Inc.
VRAY
| $171K | 0.15% |
59,100
-13,900
| -19% | -$82.4K |
|
|
TYME
97
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $170K | 0.15% |
142,500
+62,000
| +77% | +$78.2K |
|
|
MNDT
98
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $161K | 0.14% |
12,061
-1,564
| -11% | -$22.2K |
|
99
Nuwellis
NUWE
$160K
| – | – |
0
| – | – |
|
|
FOCL
100
EDAP TMS S.A.
FOCL
$229M
| $112K | 0.1% |
25,000
| – | – |
|
Similar funds
SVP
PWP
BF
SFG
HWMG
FTEA
WT
BAM
Perkins Capital Management's Q3 2019 Portfolio in Review
As of Q3 2019, Perkins Capital Management held 117 positions worth $116M, down 19% from $143M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Perkins Capital Management withdrew a net $11M in Q3 2019, closing 5 positions and reducing 64 holdings. Its most notable exit was Expeditors International, an estimated $797K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 60% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Perkins Capital Management opened a new position in Exagen worth $1.35M.
- Perkins Capital Management's largest Q3 2019 buy was Exagen: 87,450 shares worth $1.35M.
- Perkins Capital Management added most to HTG Molecular Diagnostics, Inc. Common Stock in Q3 2019, an estimated $1.97M increase.
- Perkins Capital Management's biggest Q3 2019 reduction was Magnite, cutting an estimated $2.1M.
- Perkins Capital Management fully exited Expeditors International in Q3 2019, selling an estimated $797K.
- Perkins Capital Management's ten largest holdings make up 32% of its $116M portfolio in Q3 2019.
- Perkins Capital Management opened 6 new positions and closed 5 in Q3 2019.
- Perkins Capital Management's portfolio value fell 19% quarter-over-quarter to $116M.
Based on Perkins Capital Management's 13F filing for Q3 2019, filed 23 Oct 2019.